Bespoke Extracts Inc Revenue Growth Rates (BSPK), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Bespoke Extracts Inc  (BSPK)
 

BSPK's Revenue Growth by Quarter and Year

Bespoke Extracts Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSPK Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September 0.47
2nd Quarter June 0.39
1st Quarter March 0.26
FY 1.12

BSPKs Annual Revenue
Bespoke Extracts Inc's Revenue in the fiscal year 2024 $ 1.12 millions
Bespoke Extracts Inc's Revenue in the fiscal year 2023 $ 0.79 millions
Bespoke Extracts Inc's Revenue in the fiscal year 2022 $ 0.00 millions
Bespoke Extracts Inc's Revenue in the fiscal year 2021 $ 0.04 millions
Bespoke Extracts Inc's Revenue in the fiscal year 2020 $ 0.01 millions




BSPK Revenue third quarter 2025 Y/Y Growth Comment
Bespoke Extracts Inc achieved in the third quarter 2025, above Company average Revenue rise of 67.11% year on year, to $ 0.47 millions.

Looking into third quarter 2025 results within Major Pharmaceutical Preparations industry 55 other companies have achieved higher Revenue growth. While Bespoke Extracts Inc' s Revenue jump of 67.11% ranks overall at the positon no. 479 in the third quarter 2025.


BSPK Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - 15.38 % - -
3rd Quarter September 67.11 % 16.67 % - -
2nd Quarter June 39.29 % 47.37 % - -
1st Quarter March 0 % 188.89 % - -
FY   - 43.59 % - -

Financial Statements
Bespoke Extracts Inc's third quarter 2025 Revenue $ 0.47 millions BSPK's Income Statement
Bespoke Extracts Inc's third quarter 2024 Revenue $ 0.28 millions Quarterly BSPK's Income Statement


BSPK Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - 7.14 % 8.33 % -
3rd Quarter September 19.97 % 0 % 26.32 % -
2nd Quarter June 50 % 7.69 % 111.11 % -
1st Quarter March -13.33 % 0 % - -
FY (Year on Year)   - 43.59 % - -


Back to BSPK Growth rate Comparisons >> Back to BSPK Growth rate Comparisons >>


Revenue third quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #56
Healthcare Sector #123
Overall #479

Revenue Y/Y Growth Statistics
High Average Low
43.23 % -143827.34 % -365003.63 %
(Mar 31 2025)   (Mar 31 2023)
Revenue third quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #56
Healthcare Sector #123
Overall #479
Revenue Y/Y Growth Statistics
High Average Low
43.23 % -143827.34 % -365003.63 %
(Mar 31 2025)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Bespoke Extracts Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
235.59 % 7 % -100 %
(Aug 31 2019)  


BSPK's III. Quarter Q/Q Revenue Comment
Bespoke Extracts Inc achieved in the III. Quarter 2025 above company average sequential Revenue jump of 19.97%, to $ 0.47 millions, from $0.39 millions in the second quarter.

Within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Bespoke Extracts Inc's Revenue growth quarter on quarter, overall rank is 667.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #79
Healthcare Sector #143
Overall #667
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #79
Healthcare Sector #143
Overall #667
Revenue Q/Q Growth Statistics
High Average Low
235.59 % 7 % -100 %
(Aug 31 2019)  


BSPK's III. Quarter Q/Q Revenue Comment
Bespoke Extracts Inc achieved in the III. Quarter 2025 above company average sequential Revenue jump of 19.97%, to $ 0.47 millions, from $0.39 millions in the second quarter.

Within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Bespoke Extracts Inc's Revenue growth quarter on quarter, overall rank is 667.


Bespoke Extracts Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)
Cumulative Revenue 12 Months Ending $ 1.42 $ 1.23 $ 1.12 $ 1.12 $ 1.08
Y / Y Revenue Growth (TTM) 31.76 % 17.74 % 17.05 % 42.25 % -
Year on Year Revenue Growth Overall Ranking # 806 # 251 # 264 # 0 # 0
Seqeuential Revenue Change (TTM) 15.45 % 10.03 % 0.24 % 3.47 % 3.16 %
Seq. Revenue Growth (TTM) Overall Ranking # 1330 # 433 # 479 # 484 # 507


Cumulative Revenue growth Comment
With 31.76% annual Revenue growth, Bespoke Extracts Inc would report a record annual Revenue rise if the fiscal year would end on Sep 30 2025.

In the Healthcare sector 181 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 251 to 806.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 182
Overall # 806

Revenue TTM Y/Y Growth Statistics
High Average Low
31.76 %
 -119856.71 %
-365003.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 254
S&P 500 # 1330
Cumulative Revenue growth Comment
With 31.76% annual Revenue growth, Bespoke Extracts Inc would report a record annual Revenue rise if the fiscal year would end on Sep 30 2025.

In the Healthcare sector 181 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 251 to 806.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 182
Overall # 806

Revenue TTM Y/Y Growth Statistics
High Average Low
31.76 %
-119856.71 %
-365003.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 95
Sector # 254
S&P 500 # 1330




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BSPK's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2025
Stoke Therapeutics Inc 117.25%$ 117.246 millions
Billiontoone Inc 117.12%$ 117.122 millions
Prelude Therapeutics Inc116.67%$ 116.667 millions
Eton Pharmaceuticals Inc 112.14%$ 112.143 millions
Cannapharmarx Inc 110.34%$ 110.340 millions
Harvard Apparatus Regenerative Technology Inc 108.47%$ 108.475 millions
Zivo Bioscience Inc 108.33%$ 108.333 millions
Neuronetics Inc 106.14%$ 106.144 millions
Abvc Biopharma Inc 104.47%$ 104.469 millions
Adaptive Biotechnologies Corporation102.38%$ 102.375 millions
Elite Pharmaceuticals Inc 98.23%$ 98.231 millions
Carlsmed Inc 96.16%$ 96.161 millions
Tg Therapeutics Inc 92.79%$ 92.788 millions
Bolt Biotherapeutics Inc 90.10%$ 90.096 millions
Delcath Systems Inc 88.82%$ 88.816 millions
Profound Medical Corp 86.76%$ 86.758 millions
Kaya Holdings Inc 80.27%$ 80.267 millions
Fennec Pharmaceuticals Inc 78.69%$ 78.692 millions
Vivos Therapeutics Inc 78.07%$ 78.074 millions
Insmed Inc77.99%$ 77.994 millions
Premier Air Charter Holdings Inc 75.89%$ 75.893 millions
Zymeworks Inc 72.59%$ 72.588 millions
Hologic Inc71.51%$ 71.508 millions
Legend Biotech Corporation69.99%$ 69.988 millions
Assertio Holdings inc 69.36%$ 69.357 millions
Esperion Therapeutics Inc 69.10%$ 69.099 millions
Bespoke Extracts Inc68.63%$ 68.630 millions
Xenetic Biosciences Inc 67.19%$ 67.191 millions
Geron Corporation67.05%$ 67.051 millions
Axsome Therapeutics Inc 63.22%$ 63.219 millions


About Bespoke Extracts Inc Revenue Growth Rates (BSPK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Bespoke Extracts Inc (CIK 1409197).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-25-108632
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Bespoke Extracts Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.